Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 5NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Recurrent Squamous Cell Lung Carcinoma 3Colorectal Neoplasms 2Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 15Vincristine 13Prednisone 13Rituximab 12Doxorubicin 11Etoposide 10Radiotherapy 9Methotrexate 6Filgrastim 6Cytarabine 6Gemcitabine 5Cisplatin 5VAP-cyclo protocol 4Granulocyte Colony-Stimulating Factor 4ibritumomab tiuxetan 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Leucovorin 3Immunohistochemistry 3Ifosfamide 3Gene Expression Profiling 3Dexamethasone 3pegfilgrastim 2merphos 2fludarabine 2axicabtagene ciloleucel 2Watchful Waiting 2Specimen Handling 2Mesna 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large B-Cell, Diffuse × Disulfides × Clear all
NCT05890352 2025-10-20

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

SWOG Cancer Research Network

Phase 2 Recruiting
227 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡